Specifically, ex vivo studies demonstrated enhanced phosphorylation of Akt, mTOR, and S6 in DNTs from patients with ALPS compared with those from healthy controls. This evidence concerns the gene AKT1 and autoimmune lymphoproliferative syndrome.